FdaApplication
NDA 021911
Identifiers
- fda_app_no: NDA021911
Properties
| Property | Value |
|---|---|
| applicant_name | EISAI INC |
| application_type | NDA |
| approval_date | 2008-11-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BANZEL | RUFINAMIDE | 200MG | TABLET;ORAL |
| BANZEL | RUFINAMIDE | 400MG | TABLET;ORAL |
| BANZEL | RUFINAMIDE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products